ASCO 2012: Zytiga and Xalkori highlighted by at curtain raiser
13:20 EDT 21 May 2012 | SCRIP
Johnson & Johnson's targeted anticancer Zytiga (abiraterone) and Pfizer's Xalkori (crizotinib) look set to make a splash at the upcoming American Society of Clinical Oncology meeting in Chicago, having been highlighted as being among the.....
Original Article: ASCO 2012: Zytiga and Xalkori highlighted by at curtain raiser
More From BioPortfolio on "ASCO 2012: Zytiga and Xalkori highlighted by at curtain raiser"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
